Posts Tagged 'Daytrana'

Daytrana ADHD Patch Can Cause Permanent Skin Color Loss, FDA Says

fda alerts on daytranaThe U.S. Food and Drug Administration (FDA) has released a safety communication warning that the Daytrana patch, used to treat attention deficit hyperactivity disorder (ADHD), can result in permanent loss of skin color.

The Daytrana methylphenidate transdermal system is a prescription patch marketed by Noven Pharmaceuticals for use in treating ADHD. It is supposed to increase attention and decrease distractedness in overactive children and adolescents. The manufacturer directs patients to wear the ...

continue reading...

Shire Settlement over Drug Marketing Totals $56.5 Million

In a recent announcement from the U.S. Department of Justice, a whistle-blower lawsuit against the major pharmaceutical company Shire resulted in a $56.5 million settlement. An article in First Word Pharma reports that the Shire CEO is “pleased to have reached a resolution” over the improper marketing of a number of its drugs.

The lawsuit claims that the company “violated the False Claims Act by improperly marketing and promoting several drugs.” The claim alleged that Shire was ...

continue reading...